ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,617Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 143

$394K Total Retail Price of All Prescriptions

Rank: 43 out of 143

348 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 4,860 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
SIMVASTATIN 277 222 1 2
AMLODIPINE BESYLATE 265 232 2 4
LISINOPRIL 243 174 3 1
LEVOTHYROXINE SODIUM 227 178 4 3
OMEPRAZOLE 200 116 5 5
ATORVASTATIN CALCIUM 171 104 6 7
PRAVASTATIN SODIUM 162 121 7 9
FUROSEMIDE 160 109 8 6
METFORMIN HCL 157 89 9 8
METOPROLOL SUCCINATE 155 128 10 14
HYDROCHLOROTHIAZIDE 143 123 11 10
ZOLPIDEM TARTRATE 137 84 12 13
GABAPENTIN 129 96 13 18
METOPROLOL TARTRATE 106 94 14 12
GLIMEPIRIDE 98 81 15 27
DIOVAN 92 90 16 26
WARFARIN SODIUM 92 49 16 15
FLUTICASONE PROPIONATE 91 64 18 37
SERTRALINE HCL 87 83 19 23
POTASSIUM CHLORIDE 80 49 20 34
ALENDRONATE SODIUM 78 53 21 40
NEXIUM 74 51 22 32
OXYCODONE-ACETAMINOPHEN 74 66 S2 22 56
RANITIDINE HCL 72 52 24 41
ADVAIR DISKUS 72 56 24 42
GLIPIZIDE ER 71 52 26 75
KLOR-CON 10 71 51 26 190
TRAMADOL HCL 69 52 28 16
CLOPIDOGREL 64 55 29 33
PROAIR HFA 62 24 30 48
LOSARTAN POTASSIUM 58 58 31 19
PLAVIX 55 47 32 51
ALLOPURINOL 55 51 32 39
GLIPIZIDE 54 50 34 55
METFORMIN HCL ER 51 40 35 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.